Clinical Trials Directory

Trials / Completed

CompletedNCT03805035

Anti-histamines Promote Electroacupuncture Analgesia: Basic and Clinical Research

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

Acupuncture has been used in traditional Chinese medicine for around 3,000 years and is increasingly practiced worldwide. The effects of acupuncture in chronic pain have been investigated in many clinical trials. Histamine H1 receptor antagonists are commonly used for treating allergy. Recently, investigators found that histamine H1 receptor antagonists at relatively low doses facilitate EA analgesia in the acetic acid-induced abdominal writhing test. Investigators aim to further explore whether histamine H1 receptor antagonists also facilitate EA analgesia in humans.The aims of the proposed studies are to: Conduct a clinical trial to demonstrate that H1 receptor antagonists at relatively low doses facilitate EA analgesia in healthy volunteers. This study will recruit 40 healthy normal subjects (aged between 20 and 30 years) who will be randomly assigned to one of four groups: (1) Sham acupuncture (Shallow needling without electrical stimulation) at ST36 and GB34; (2) EA at ST36 and GB34; (3) EA at ST36 and GB34 plus low-dose chlorpheniramine (2 mg); (4) EA at ST36 and GB34 plus regular-dose chlorpheniramine (4 mg). The primary endpoint will be the pain threshold. It is expected that the completion of this proposed study will enhance our knowledge as to how acupuncture analgesia can be promoted by antihistamine drugs given at a low dose and help to define its application for clinical use.

Conditions

Interventions

TypeNameDescription
DEVICEelectroacupunctureGroup 2 (n=10) EA at ST36 and GB34;intensity (2 mA), pulse width (1 ms), frequency (2 Hz)
DRUGantihistamine(low dose) chlorpheniramine (Dexchlorpheniramine maleate)Group 3 (n=10) EA at ST36 and GB34 plus chlorpheniramine (Dexchlorpheniramine maleate 2mg/tab, 1 tab);intensity (2 mA), pulse width (1 ms), frequency (2 Hz)
DRUGantihistamine(high dose) chlorpheniramine (Dexchlorpheniramine maleate)Group 4 (n=10) EA at ST36 and GB34 plus chlorpheniramine (Dexchlorpheniramine maleate2mg/tab, 2 tabs);intensity (2 mA), pulse width (1 ms), frequency (2 Hz)
DEVICEacupunctureMinimal needling at ST36 and GB34

Timeline

Start date
2019-01-24
Primary completion
2019-06-27
Completion
2019-06-30
First posted
2019-01-15
Last updated
2020-01-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03805035. Inclusion in this directory is not an endorsement.